Zelsuvmi — Blue Cross Blue Shield of Montana
rare diseases or off-label indications for BCBS NM Fully Insured, NM HIM, or OH members
Initial criteria
- BCBS NM Fully Insured or NM HIM members: ALL of the following: (A) The patient does NOT have any FDA labeled contraindications to the requested agent AND (B) The requested indication is a rare disease AND ONE of the following: (1) The patient has another FDA labeled indication for the requested agent and route of administration OR (2) The patient has another indication that is supported in compendia for the requested agent and route of administration
- OR ALL of the following: (A) The member resides in Ohio AND (B) The plan is Fully Insured or HIM Shop (SG) AND (C) The patient does NOT have any FDA labeled contraindications to the requested agent AND ONE of the following: (1) The patient has another FDA labeled indication for the requested agent and route of administration OR (2) The patient has another indication that is supported in compendia for the requested agent and route of administration OR (3) The prescriber has submitted TWO articles from major peer-reviewed professional medical journals supporting the proposed use as generally safe and effective (acceptable study designs may include randomized, double-blind, placebo-controlled clinical trials; case studies not acceptable)
Approval duration
12 months